Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2).

Yosipovitch G, Kim BS, Kwatra SG, Mollanazar NK, Ständer S, Satoh T, Mendes-Bastos P, Tsai TF, Laws E, Nivens MC, Maloney J, Shi G, Bansal A, Dubost-Brama A.

Open source

DOI: 10.1016/j.jdin.2024.03.025
Published: 2024-04-10
Container: JAAD Int
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jdin.2024.03.025,
  title = {Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2).},
  author = {Yosipovitch G and  Kim BS and  Kwatra SG and  Mollanazar NK and  Ständer S and  Satoh T and  Mendes-Bastos P and  Tsai TF and  Laws E and  Nivens MC and  Maloney J and  Shi G and  Bansal A and  Dubost-Brama A.},
  year = {2024},
  journal = {JAAD Int},
  doi = {10.1016/j.jdin.2024.03.025},
  url = {https://doi.org/10.1016/j.jdin.2024.03.025}
}

RIS

TY  - JOUR
TI  - Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2).
AU  - Yosipovitch G
AU  -  Kim BS
AU  -  Kwatra SG
AU  -  Mollanazar NK
AU  -  Ständer S
AU  -  Satoh T
AU  -  Mendes-Bastos P
AU  -  Tsai TF
AU  -  Laws E
AU  -  Nivens MC
AU  -  Maloney J
AU  -  Shi G
AU  -  Bansal A
AU  -  Dubost-Brama A.
PY  - 2024
JO  - JAAD Int
DO  - 10.1016/j.jdin.2024.03.025
UR  - https://doi.org/10.1016/j.jdin.2024.03.025
ER  -

APA

G, Y., BS, K., SG, K., NK, M., S, S., T, S., P, M., TF, T., E, L., MC, N., J, M., G, S., A, B., & A., D. (2024). Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2).. JAAD Int. https://doi.org/10.1016/j.jdin.2024.03.025

Source records

europe-pmc · retrieved 2026-09-25T19:06:30.716Z
doaj · retrieved 2026-09-25T19:06:30.726Z